An Introduction to the Improved FDA Prescription Drug Labeling
Speaker Biographies
Mary E. Kremzner, Pharm.D., CDR, U.S. Public Health Service
Dr. Kremzner is the Deputy Director of the Division of Drug Information within the Center
for Drug Evaluation and Research (CDER) at the Food and Drug Administration. In this capacity,
she supervises a staff of pharmacists charged with the responsibility of responding to inquiries
from a broad range of sources, including regulated industry, academia, consumers, health care
professionals and others.
Dr. Kremzner continues to work part-time in a community pharmacy position to maintain her
skills as a practicing pharmacist.
Dr. Kremzner received her degrees from the University of Maryland, School of Pharmacy.
Steven F. Osborne, M.D., Medical Officer, Food and Drug Administration
Dr. Osborne is a Medical Officer in the Office of Nonprescription Products within the Center
for Drug Evaluation and Research (CDER) at the Food and Drug Administration. In this capacity,
he reviews new drug applications for over-the-counter drugs and participates in the preparation
of final monographs for the over-the-counter drug review.
Prior to joining FDA, Dr. Osborne practiced internal medicine in the private sector and for a
HMO. He has organized and participated in medical missions to remote areas of Haiti since 2001.
Dr. Osborne received his undergraduate degree in chemistry from the University of Notre Dame
and his medical degree from the Georgetown University School of Medicine.
Back to Top
| 
PDF requires the free